Biopharma Co. Nets $120M To Research Quality Control Tech
A biopharmaceutical company said Wednesday that it raised $120 million to advance its quality control tests during a funding round led by private equity firm Ally Bridge Group....To view the full article, register now.
Already a subscriber? Click here to view full article